We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.
Third quarter 2024 results
October 29, 2024 | Basel, Switzerland
Media release: English (PDF 0.4 MB) | Deutsch (PDF 0.5 MB)
Interim financial report (PDF 0.6 MB)
Watch the webcast
Download the presentation (PDF 6.5 MB)
Download the podcast (MP3 31 MB)
Novartis Q3 2024 impact and sustainability update (PDF 0.6 MB)
Investors event calendar
View recent presentations and learn more about upcoming events.
November 12, 2024
Guggenheim Global Healthcare Conference | Boston, USA
UBS Global Healthcare Conference | Ranchos Palo Verdes, USA
Environmental, Social and Governance (ESG)
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.
ESG updates: October 2024 (PDF 0.6 MB) | July 2024 (PDF 0.9 MB) | April 2024 (PDF 1.0 MB) | February 2024 (PDF 0.6 MB)
Latest updates: Impact & Health Equity (PDF 9.9 MB) | Novartis Enterprise Risk Management (PDF 0.2 MB) | Materiality Assessment
We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.
Stocks
Reporting and transparency hub
Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.